Endurant Capital Management LP - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 275 filers reported holding HAEMONETICS CORP in Q3 2019. The put-call ratio across all filers is 2.28 and the average weighting 0.1%.

Quarter-by-quarter ownership
Endurant Capital Management LP ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q4 2021$3,920,000
-50.1%
73,914
-37.3%
0.95%
-56.2%
Q2 2021$7,857,000
+367.4%
117,904
+678.8%
2.16%
+392.9%
Q1 2021$1,681,000
-53.7%
15,139
-63.6%
0.44%
-59.2%
Q3 2020$3,630,000
+40.0%
41,607
+43.8%
1.07%
+655.6%
Q2 2020$2,592,000
-36.9%
28,937
-11.2%
0.14%
-90.4%
Q3 2019$4,111,000
+602.7%
32,594
+387.1%
1.48%
+538.5%
Q1 2019$585,0006,6910.23%
Other shareholders
HAEMONETICS CORP shareholders Q3 2019
NameSharesValueWeighting ↓
BEACONLIGHT CAPITAL, LLC 95,033$8,511,0002.84%
Advantage Alpha Capital Partners LP 100,170$8,971,0002.10%
Nitorum Capital, L.P. 395,635$35,433,0001.82%
Summit Creek Advisors LLC 127,600$11,428,0001.68%
Bridge City Capital, LLC 40,559$3,632,0001.67%
AEGON ASSET MANAGEMENT UK PLC 520,408$46,603,0001.05%
Jackson Square Partners, LLC 2,298,190$205,825,0001.03%
Parkman Healthcare Partners LLC 30,147$2,700,0000.76%
TEALWOOD ASSET MANAGEMENT INC 9,154$820,0000.54%
AMERICAN CAPITAL MANAGEMENT INC 159,145$14,253,0000.52%
View complete list of HAEMONETICS CORP shareholders